SCHEMBL609364

SCHEMBL609364

OC(CN1CCN(c2ccccn2)CC1)Cn1c2ccccc2c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 1.00
ALDH1A1 P00352 6/20 1.00
MAPT P10636 5/20 1.00
POLB P06746 3/20 1.00
HSD17B10 Q99714 3/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
MAPK1 P28482 2/20 1.00
HPGD P15428 1/20 1.00
KDM4E B2RXH2 3/20 0.76
HTT P42858 1/20 0.76
GAA P10253 1/20 0.60
ALOX15 P16050 2/20 0.59
TSHR P16473 1/20 0.59
ATM Q13315 1/20 0.59
RAD52 P43351 1/20 0.57
TP53 P04637 1/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
BACE1 P56817 1/20 0.55
IGF1R P08069 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022558 0.86 LMNA (1.00) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL6815269 0.84 POLB (0.84) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL12781849 0.81 LMNA (0.68) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL1305673 0.81 MAPT (0.67) LMNAALDH1A1MAPTPOLBHSD17B10
Hydrochloric Acid SCHEMBL9493281 0.80 LMNA (0.67) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL7291269 0.80 LMNA (0.67) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL11104845 0.78 ALDH1A1 (0.63) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL11108098 0.78 LMNA (0.63) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL10587768 0.77 IGF1R (0.64) LMNAALDH1A1MAPTPOLBHSD17B10
SCHEMBL30874651 0.77 IGF1R (0.64) LMNAALDH1A1MAPTPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP claimed
EP-1094063-A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators Applied Research Systems ARS Holding N.V. (AN) 2001-04-25 EP claimed
US-8410110-B2 9-(piperazinylalkyl) carbazoles as Bax-modulators MERCK SERONO SA (CH) 2013-04-02 US disclosed
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2012-02-16 US disclosed
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP disclosed
EP-1094063-A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators Applied Research Systems ARS Holding N.V. (AN) 2001-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS BCL2, BAX, BAD LMNA 55/4885ALDH1A1 2766/4885MAPT 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.